MolDX Biomarker Testing for Risk Stratification in DCIS-Retirement - Effective October 8, 2026

Date Posted: October 8, 2026

This proposed Local Coverage Determination (LCD) has been retired under contractor 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Medicare Coverage Database (MCD) Number: DL40144

LCD Title: MolDX Biomarker Testing for Risk Stratification in DCIS

Effective Date: October 8, 2026

Rationale: Medicare Administrative Contractors (MACs) take significant care and consider all the available evidence relevant to the local coverage determinations (LCDs) they publish. Given the numerous Comments received related to current and impending clinical evidence to be considered, this MAC has decided to retire the following draft LCD: MolDX Biomarker Testing for Risk Stratification in DCIS (DL40144).

As such, the Contractor Advisory Committee Meeting, scheduled for October 13, 2026, will be canceled. Any further updates on this topic will be provided on our website.

To access retired proposed LCDs, visit the CMS Medicare Coverage Database Archive.

Last Updated Oct 08 , 2026